We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.38B
AUM Growth
+$132M
Cap. Flow
+$91.6M
Cap. Flow %
6.65%
Top 10 Hldgs %
28.56%
Holding
1,934
New
622
Increased
464
Reduced
326
Closed
465

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Communication Services 8.62%
3 Healthcare 8.45%
4 Financials 8.14%
5 Consumer Discretionary 5.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDWR icon
1226
Radware
RDWR
$1.19B
$23K ﹤0.01%
1,095
-2,424
-69% -$50.2K
SPTN
1227
DELISTED
SpartanNash
SPTN
$23K ﹤0.01%
1,359
-4,472
-77% -$95.9K
TITN icon
1228
Titan Machinery
TITN
$445M
$23K ﹤0.01%
956
-300
-24% -$6.28K
TPH
1229
DELISTED
Tri Pointe Homes
TPH
$23K ﹤0.01%
1,400
-1,130
-45% -$19.4K
IMGN
1230
DELISTED
Immunogen Inc
IMGN
$23K ﹤0.01%
+2,200
New +$21.7K
BBQ
1231
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
$23K ﹤0.01%
+3,235
New +$21.6K
ECYT
1232
CALL
DELISTED
Endocyte, Inc. Common Stock
ECYT
$23K ﹤0.01%
+2,500
New +$13.8K
FNSR
1233
DELISTED
Finisar Corp
FNSR
$23K ﹤0.01%
+1,471
New +$27.8K
ABEO icon
1234
Abeona Therapeutics
ABEO
$413M
$22K ﹤0.01%
62
+14
+29% +$5.2K
BF.B icon
1235
PUT
Brown-Forman Class B
BF.B
$13.1B
$22K ﹤0.01%
+400
New +$19K
MDLZ icon
1236
Mondelez International
MDLZ
$79.9B
$22K ﹤0.01%
+535
New +$23.2K
STAA icon
1237
STAAR Surgical
STAA
$1.21B
$22K ﹤0.01%
1,500
-139
-8% -$2.17K
BERY
1238
DELISTED
Berry Global Group, Inc.
BERY
$22K ﹤0.01%
+441
New +$23K
AOI
1239
DELISTED
Alliance One International
AOI
$22K ﹤0.01%
853
-3,257
-79% -$61.2K
BNED icon
1240
Barnes & Noble Education
BNED
$443M
$21K ﹤0.01%
31
+22
+244% +$15.5K
DXJ icon
1241
WisdomTree Japan Hedged Equity Fund
DXJ
$7.42B
$21K ﹤0.01%
368
-528
-59% -$30.7K
GGG icon
1242
Graco
GGG
$13.5B
$21K ﹤0.01%
465
-3,780
-89% -$172K
GNK icon
1243
Genco Shipping & Trading
GNK
$1.1B
$21K ﹤0.01%
+1,500
New +$20.9K
KOP icon
1244
Koppers
KOP
$969M
$21K ﹤0.01%
+500
New +$22K
MTZ icon
1245
MasTec
MTZ
$21.9B
$21K ﹤0.01%
452
-32
-7% -$1.62K
RIGL icon
1246
Rigel Pharmaceuticals
RIGL
$750M
$21K ﹤0.01%
591
+29
+5% +$1.16K
VTOL icon
1247
Bristow Group
VTOL
$1.36B
$21K ﹤0.01%
+1,100
New +$22.1K
ALDX icon
1248
Aldeyra Therapeutics
ALDX
$93.5M
$20K ﹤0.01%
2,731
+1,378
+102% +$10.5K
BXC icon
1249
BlueLinx
BXC
$706M
$20K ﹤0.01%
+600
New +$11.1K
CRK icon
1250
Comstock Resources
CRK
$3.94B
$20K ﹤0.01%
+2,683
New +$21.7K

Similar funds

Prelude Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Prelude Capital Management held 1,934 positions worth $1.38B, up 11% from $1.25B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Prelude Capital Management deployed $91.6M of net new capital in Q1 2018, opening 622 new positions and adding to 464 existing holdings. Its largest new stake was XL Group Ltd.: 571,194 shares worth $31.6M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Twenty-First Century Fox, Inc. Class B, an estimated $10.5M trimmed.

  • Prelude Capital Management's largest Q1 2018 buy was XL Group Ltd.: 571,194 shares worth $31.6M.
  • Prelude Capital Management added most to NXP Semiconductors in Q1 2018, an estimated $19.7M increase.
  • Prelude Capital Management's biggest Q1 2018 reduction was Twenty-First Century Fox, Inc. Class B, cutting an estimated $10.5M.
  • Prelude Capital Management fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $21.7M.
  • Prelude Capital Management's ten largest holdings make up 29% of its $1.38B portfolio in Q1 2018.
  • Prelude Capital Management opened 622 new positions and closed 465 in Q1 2018.
  • Prelude Capital Management's portfolio value rose 11% quarter-over-quarter to $1.38B.

Based on Prelude Capital Management's 13F filing for Q1 2018, filed 15 May 2018.